{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:08:34Z","timestamp":1787972914088,"version":"build-2784847793"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.reuma.2019.10.001","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T19:00:37Z","timestamp":1575486037000},"page":"250-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Autoantibodies to extractable nuclear antigens (ENAs) pattern in rheumatoid arthritis patients: Relevance and clinical implications"],"prefix":"10.1016","volume":"17","author":[{"given":"Yasser","family":"Emad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Ragab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevin","family":"Hammam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nashwa","family":"El-Shaarawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ossama","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania M.","family":"Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdy","family":"Abd-Elsalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem H.A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Hawass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes J.","family":"Rasker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2019.10.001_bib0005","first-page":"30051","article-title":"Role of rheumatoid factor isotypes and anti-citrullinated peptide antibodies in the differential diagnosis of non-selected patients with inflammatory arthralgia","author":"Hermosillo-Villafranca","year":"2019","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reuma.2019.10.001_bib0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0896-8411(88)90008-X","article-title":"Clinical implications of the presence of anti-Ro (SSA) antibodies in patients with rheumatoid arthritis","volume":"1","author":"Skopouli","year":"1988","journal-title":"J Autoimmun"},{"key":"10.1016\/j.reuma.2019.10.001_bib0015","first-page":"149","article-title":"Anti-Ro antibodies in rheumatoid arthritis","volume":"37","author":"Zanlorenzi","year":"2012","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.reuma.2019.10.001_bib0020","first-page":"59","article-title":"Anti-Ro\/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations","volume":"24","author":"Cavazzana","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reuma.2019.10.001_bib0025","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1097\/MD.0000000000000523","article-title":"Club Rhumatismes et Inflammation. In antisynthetase syndrome ACPA are associated with severe and erosive arthritis: an overlapping rheumatoid arthritis and antisynthetase syndrome","volume":"94","author":"Meyer","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.reuma.2019.10.001_bib0030","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00296-010-1467-5","article-title":"Antisynthetase syndrome associated with long-standing rheumatoid arthritis","volume":"31","author":"Nagashima","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reuma.2019.10.001_bib0035","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jbspin.2015.10.014","article-title":"Rheumatoid arthritis and antisynthetase syndrome. A three cases report","volume":"83","author":"Wendling","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.reuma.2019.10.001_bib0040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10067-010-1666-1","article-title":"A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept","volume":"30","author":"Ishikawa","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reuma.2019.10.001_bib0045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00296-009-1222-y","article-title":"Development of antisynthetase syndrome in a patient with rheumatoid arthritis","volume":"31","author":"Park","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reuma.2019.10.001_bib0050","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.3899\/jrheum.091402","article-title":"Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome","volume":"37","author":"Cavagna","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2019.10.001_bib0055","first-page":"30116","article-title":"Antisynthetase syndrome complicating the course of established case with rheumatoid arthritis: a rare and under-recognized overlapping disease","volume":"S1699\u2013258X","author":"Emad","year":"2018","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reuma.2019.10.001_bib0060","first-page":"315179","article-title":"Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","author":"Mahler","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.reuma.2019.10.001_bib0065","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/0961203308097784","article-title":"Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus","volume":"18","author":"Agarwal","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.reuma.2019.10.001_bib0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4081\/reumatismo.2018.1027","article-title":"Antibodies to extractable nuclear antigens (ENAs) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity","volume":"70","author":"Emad","year":"2018","journal-title":"Reumatismo"},{"key":"10.1016\/j.reuma.2019.10.001_bib0075","first-page":"1267","article-title":"Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus","volume":"32","author":"Faria","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2019.10.001_bib0080","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1177\/0961203314524850","article-title":"Rare autoantibodies to cellular antigens in systemic lupus erythematosus","volume":"23","author":"Fredi","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.reuma.2019.10.001_bib0085","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reuma.2019.10.001_bib0090","first-page":"598","article-title":"What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3","volume":"35","author":"Flechsig","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reuma.2019.10.001_bib0095","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/1756-185X.12880","article-title":"Anti-Sm is associated with the early poor outcome of lupus nephritis","volume":"19","author":"Ahn","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.reuma.2019.10.001_bib0100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/bmj.1.5230.933","article-title":"Clinical study of serum antinuclear factor","volume":"1","author":"Weir","year":"1961","journal-title":"Br Med J"},{"key":"10.1016\/j.reuma.2019.10.001_bib0105","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/ard.39.6.550","article-title":"Seronegative chronic polyarthritis: clinical and serological correlates","volume":"39","author":"Rasker","year":"1980","journal-title":"Annals Rheum Dis"},{"key":"10.1016\/j.reuma.2019.10.001_bib0110","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/art.1780230913","article-title":"Correlation between anti-RANA and anti-EBNA titers in normal subjects with and without HLA-DRw4","volume":"23","author":"Catalano","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2019.10.001_bib0115","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI110083","article-title":"Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis","volume":"67","author":"Ferrell","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.reuma.2019.10.001_bib0120","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/art.1780241201","article-title":"Titers of antibodies to RANA in rheumatoid arthritis and normal sera relationship to Epstein-Barr virus infection","volume":"24","author":"Venables","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2019.10.001_bib0125","first-page":"305","article-title":"The incidence of anti-RANA in Mexican Mestizo populations with rheumatoid arthritis or other conditions","volume":"10","author":"Reyes","year":"1983","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2019.10.001_bib0130","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2019.10.001_bib0135","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/art.1780140605","article-title":"Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities","volume":"14","author":"Sharp","year":"1971","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2019.10.001_bib0140","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3109\/s10165-010-0286-6","article-title":"Prevalence and predictive value of anti-cyclic citrullinated protein antibodies for future development of rheumatoid arthritis in early undifferentiated arthritis","volume":"20","author":"Emad","year":"2010","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.reuma.2019.10.001_bib0145","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10067-014-2569-3","article-title":"In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up","volume":"33","author":"Emad","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reuma.2019.10.001_bib0150","article-title":"Is palindromic rheumatism a pre-rheumatoid arthritis condition? Low incidence of rheumatoid arthritis in palindromic rheumatism patients treated with tight control strategy","volume":"13","author":"Khabbazi","year":"2019","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reuma.2019.10.001_bib0155","article-title":"Frequency of ANA\/DFS70 in relatives of patients with rheumatoid arthritis compared to patients with rheumatoid arthritis and a healthy population, and its association with health status","volume":"16","author":"Romero-\u00c1lvarez","year":"2019","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reuma.2019.10.001_bib0160","doi-asserted-by":"crossref","first-page":"e0185104","DOI":"10.1371\/journal.pone.0185104","article-title":"Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: results from a routine population survey","volume":"12","author":"Jardel","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.reuma.2019.10.001_bib0165","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13256-017-1333-0","article-title":"Methotrexate-induced hypersensitivity pneumonitis appearing after 30 years of use: a case report","volume":"11","author":"Salehi","year":"2017","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.reuma.2019.10.001_bib0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0970-2113.173055","article-title":"Antisynthetase syndrome: an under-recognized cause of interstitial lung disease","volume":"33","author":"Maturu","year":"2016","journal-title":"Lung India"},{"key":"10.1016\/j.reuma.2019.10.001_bib0175","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.reuma.2015.03.012","article-title":"Calcinosis in hands and antisynthetase syndrome without muscle involvement","volume":"12","author":"Garc\u00eda Rodr\u00edguez","year":"2016","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reuma.2019.10.001_bib0180","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1699-258X(07)73704-X","article-title":"Antisynthetase syndrome without muscle involvement","volume":"3","author":"J\u00fadez Navarro","year":"2007","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reuma.2019.10.001_bib0185","first-page":"1","article-title":"Autoantibodies to extractable nuclear antigens: making detection and interpretation more meaningful","volume":"9","author":"Phan","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.reuma.2019.10.001_bib0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3899\/jrheum.160618","article-title":"Negative antinuclear antibody does not indicate autoantibody negativity in myositis: role of anticytoplasmic antibody as a screening test for antisynthetase syndrome","volume":"44","author":"Aggarwal","year":"2017","journal-title":"J Rheumatol"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X19301287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X19301287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:01:06Z","timestamp":1761663666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X19301287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1699258X19301287"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2019.10.001","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies to extractable nuclear antigens (ENAs) pattern in rheumatoid arthritis patients: Relevance and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2019.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}